Glofitamab in B-NHL Using Mid-Therapy Intratumoral Transcriptomics

by palligoelme@gmail.com | Aug 5, 2026 | Clinical Trials

​ Conditions: Relapsed/Refractory Diffuse Large B-cell Lymphoma; Relapsed/Refractory Mantle Cell Lymphoma Interventions: Biological: Glofitamab Sponsors: Joshua Brody; Genentech, Inc. Not yet recruiting Conditions: Relapsed/Refractory Diffuse Large B-cell Lymphoma;...

The Reliability and Validity of Little’s Irregularity Index Assessment

by palligoelme@gmail.com | Aug 5, 2026 | Clinical Trials

​ Conditions: Dental Crowding; Malocclusion, Angle Class I Sponsors: Al-Azhar University Completed Conditions: Dental Crowding; Malocclusion, Angle Class I Sponsors: Al-Azhar University Completed 

Caffeine Intake and Periodontal Treatment Outcomes

by palligoelme@gmail.com | Aug 5, 2026 | Clinical Trials

​ Conditions: Periodontitis Interventions: Dietary Supplement: No Caffeine Intake; Dietary Supplement: Low Caffeine Intake; Dietary Supplement: Moderate Caffeine Intake Sponsors: Haoran Feng; Affiliated Stomatological Hospital of Xuzhou Medical University Not yet...

Study on Clinical and Pathological Features of Primary Biliary Cholangitis and Risk Factors Related to Disease Progression

by palligoelme@gmail.com | Aug 4, 2026 | Clinical Trials

​ Conditions: PBC Sponsors: Beijing Municipal Administration of Hospitals Not yet recruiting Conditions: PBC Sponsors: Beijing Municipal Administration of Hospitals Not yet recruiting 

Tregs and miRNAs in Breast Milk: Effects on Infant Food Tolerance

by palligoelme@gmail.com | Aug 4, 2026 | Clinical Trials

​ Conditions: Immune Tolerance; Food Tolerance Sponsors: Istanbul University Recruiting Conditions: Immune Tolerance; Food Tolerance Sponsors: Istanbul University Recruiting